AffirmHealth Blog

bigstock-FDA-food-and-drug-administrati-119610116

The Controversial Approval of Dsuvia by the Food and Drug Administration

Nov 21, 2018 8:23:13 AM by Mario Ramirez, MD posted in Opioid Epidemic, Opioid Therapy, Raeford Brown, dsuvia, FDA

Earlier this month on November 2nd, the U.S. Food and Drug Administration approved Dsuvia, a new sublingual version of an older drug, sufentanil, that has been in use since 1984. 

Read More
Weekend Round Up

Weekend Round Up: Healthcare Databases, Chronic Pain Patients Feel Caught in Debate and State Updates for Florida, and Connecticut

Jul 8, 2018 7:57:02 PM by Jody Lutz posted in Healthcare, Opioid Epidemic, Opioid Misuse, chronic pain, Integrated Pain, Opioid Therapy, Opioid Doses, Smarter Pain Management, Guidelines, Clinical Tools, State Opioid Prescibing Guidelines, Opioid Prescribing Guidelines, Chronic Pain Guidelines, prescriber compliance, regulations, compliance, opioid prescribing, opioid prescribing compliance, prescription drug monitoring, weekend round up, Medication Assisted Treatment Protocols, tapering, patient safety, Arizona, opioid legislation, opioid abuse, florida, Healthcare Databases, Connecticut, controlled substances

With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.

Read More
Weekend Round Up

Weekend RoundUp: Ketamine Guidelines, Kentucky Sues Walgreens, SAMSHA Updates Opioid Toolkit and more

Jun 17, 2018 5:54:48 PM by Jody Lutz posted in Opioid Epidemic, Opioid Misuse, chronic pain, Opioid Therapy, Pain Management, Guidelines, weekend round up, patient safety, Kentucky, Ketamine

With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.

Read More
Weekend Round Up

Weekend Round Up

Jun 10, 2018 1:23:23 PM by Jody Lutz posted in Opioid Epidemic, Opioid Therapy, State Opioid Prescibing Guidelines, Opioid Prescribing Guidelines, prescriber compliance, opioid prescribing, prescription drug monitoring, weekend round up, Pain Guidelines, patient risk

With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.

Read More
Weekend Round Up

Weekend Round Up

Jun 3, 2018 1:54:06 PM by Jody Lutz posted in Opioid Epidemic, Opioid Therapy, Opioid Doses, Tennessee, State Opioid Prescibing Guidelines, Chronic Pain Guidelines, regulations, opioid prescribing, Medical Necessity, prescription drug monitoring, Pain Guidelines, tapering, Michigan, Arizona

With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.

Read More
Weekend Round Up

Weekend Round Up: Memorial Day Edition

May 27, 2018 12:49:05 PM by Jody Lutz posted in Healthcare, Opioid Epidemic, Opioid Misuse, Opioid Therapy, prescriber compliance, regulations, prescription drug monitoring, weekend round up, prescribing protocols, Treatment Agreements, Informed Consent, Michigan

With opioid prescribing regulations being updated, national policy announcements, state guidelines as well as daily commentary regarding the opioid epidemic flooding news outlets, the AffirmHealth Weekend Round Up looks at the top headlines that caught our team’s eye. From controlled substance protocols to research focusing on pain management, addiction medicine, the ER and more provided to you in an easy to access summary. News you can use. Welcome to the Weekend Round Up.

Read More
New Toolkit Supports Providers with Prescribing Guidelines - Naomi Kuznets.png

New Toolkit Supports Providers with Prescribing Guidelines

Jun 6, 2017 10:59:56 AM by Mitch Evans posted in Opioid Therapy, Smarter Pain Management, Guidelines, Clinical Tools

The Accreditation Association for Ambulatory Healthcare, Inc. (AAAHC) has released a new toolkit to combat opioid overdose through improved stewardship programs. The resource is designed to help providers review and assess the volume and length of opioid prescriptions and dosages to mitigate risk of patient overdose and death.

Read More

Do Higher Opioid Doses Lead To Worse Outcomes?

May 1, 2017 6:30:00 AM by Mitch Evans posted in Research, Opioid Therapy, Pain Management, Opioid Doses

A recent study published in The Journal of Pain found that patients prescribed higher opioid doses experienced greater pain intensity, higher health care utilization, and poorer quality of life. Is this a breakthrough finding or an obvious correlation?

Read More

The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.

Comments